Status:
COMPLETED
Biomarkers in Pulmonary Hypertension Associated to Interstitial Lung Disease
Lead Sponsor:
University of Aarhus
Conditions:
Interstitial Lung Disease
Pulmonary Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
The presence of an abnormally increased pulmonary blood pressure worsens the prognosis of patients with interstitial pulmonary disease. The aim of this study is to estimate the frequency of an increa...
Detailed Description
The presence of increased pulmonary blood pressure is established by echocardiography and confirmed by right heart catheterization. The ability of NT-proBNP, vWf, troponin-t, D-dimer and exhaled NO t...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Interstitial pulmonary disease
Exclusion
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
212 Patients enrolled
Trial Details
Trial ID
NCT00820729
Start Date
March 1 2009
End Date
March 1 2011
Last Update
September 18 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Pulmonary Diseases, Århus Sygehus
Aarhus, Denmark, Dk-8000
2
Department of Cardiology, Skejby sygehus
Århus N, Denmark, DK-8200